<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 70 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page69.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=70">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 70 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 70</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=70"><img src="../thumb/70.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.6                                                    2020-04 / 39
       clear.of OC’s oestrog.compon incr.signific., incr.peak conc. & AUC with   digoxin/ nicardipine/ nimodipine/quinidine/verapamil/ corticoster./   in neonates. esp. prems, concurr.alcoh.use, lact.intol., safety & effic.
       hydrochlorothiazide, incr.AUC & peak conc.of metformin.  warfar/furosemide/oestrog./OC’s/ diazoxide/ alcuronium/pancuro-  in ren.& hepat.funct.impairm.not stud., no clinic. trial exper.in panic
       PHENYTOIN SODIUM 100 mg, (Aspen Pharmacare:   nium/ vecuronium/ methadone/ chlorpropamide/glyburide/ tolbu-  disord.in pts. Und.18 yrs. & over 65 yrs.& old.
                                     tamide/clozapine/paroxetine/sertraline/ Vit.D. TCA’s may precipit.
                                                                  Side effects: Saliv./bronch.hypersecret.in infts.& small childr., de-
       Pharma) Pharmacare [P/S]      seiz.in suscept.indiv.       pend., somnol., headache, upper resp. infect., fatig., flu, depress.poss.
       Phenytoin sodium                                           assoc.with underly. dis., dizzin., CNS/psych.eff., atax., incr. seiz. freq.
       Indications: Grand mal & psychomot.epilep.  REDILEV, Dr Reddy’s [P/S]  of cert.epilept.dur.long-term treatm., GI/ co-ordinat. disturbs., light-
       (S3) TABS, B884               Levetiracetam                headedn., sinusit., bld. dyscras., allerg.reacts.incl.anaphylax., revers.
       754870-016: 100 mg, 90, R60,07  Indications: Monother. of newly diagn.part.onset seiz. with/-out sec-  developm. of prem.second.sex characterist.in childr., loss of libido,
       754870-015: 100 mg, 1 000, R667,47  ond.generalisat., as adjunct. ther. in part.onset seiz.with/without sec-  musc.hypoton./weakn., vis. disturbs., nystagm., thrombophlebit.,
       Dosage: 50-100 mg 3xdly.incr.to 200 mg 3xdly as necess.aft.meals.  ond. generalisat. in adults & adolesc.over 16 yrs.with epilep., adjunct.  resp.depress. esp.on IV admin., skin reacts.incl.pigmentat. chang.,
       Contraindications: Card.funct.impairm.eg Adams Stokes syndr.,   ther.in myoclon.seiz.in adults & juvenile myoclon.epilep.in adolesc.  temp.hair loss, urin.incont., impot., incr. falls/ fract.risk, dysarthr.,
       sinoatr.block & sinus bradycard.  from 12 yrs., adjunct. ther.in prim.generalis.ton.-clon.seiz.in adults &   anterogr.amnes.somet. assoc. with inappropr.behav., status epilept.
       Side effects: GI disturbs., atax., slurr.speech, blurr. vis., nystagm.,   idiopath.general.epilep.in adolesc.from 16 yrs.  poss. precipit. with abrupt withdr., rebound effs., Inj: perman. neu-
       ment.confus.& hallucinat., CNS effs., gum hyperplas.& tendern.esp.  (S3) TABS, 41/2.5/0460, 0461, 0462  ropsych.deficits & multiple syst.organ fail. assoc.with benzyl alcoh.
       young pts, hirsut., rickets, reduc.bone density, osteomalac., lupus ery-  714662-001: 250 mg, 30, R98,00  used as preservat.in amps.
       thematos., lymphadenopathy, bld. dyscras., skin rash  714663-001: 500 mg, 30, R137,09  Special precautions: Passes into breast milk, monit. infts & small
       Special precautions: Withdr.immed.if bld. dyscras.develop., withdr.  714663-003: 750 mg, 30, R273,50  childr.to ensure free airways, abuse potent., alcoh./drug abuse hist.,
       if bullous/exfoliat/ purpur.rash develops, thyroid replacem.ther., early   Dosage: Admin.dly.dos.in 2 equal.div.dos.  spin./ cerebell. atax., ac.alcoh.intoxicat., hypnot., analges., neurolept.
       pregn. & breast feed., GI ulc., calciferol 100 µg/wk recomm.in long   Monother: Adults & adolesc.from 16 yrs: Recomm.start.dos:   agents, anti-depress., Li, elderly, pre-exist.resp./liv./kidn.dis., other
       term.ther., diab.mellit., porphyr., cont.lact.  250 mg 2xdly.incr.to init. therap.dos.of 500 mg 2xdly aft.2  wks. May   concom. central.act.meds./barbits./anticonvuls., depress. hist. &/
       Drug interactions: Dicoumarol/disulfiram/ isoniazid/chloramphen-  be incr.furth.by 250 mg 2xdly every 2 wks.depend.on clinic.respons.   suic.attempt, per.re-eval.of longt.ther., maint. airway patency, grad.
       ic./halothane/ phenyramidol/ sulthiame/thyroid preps.& viloxazine   Max.dly.dos: 1 500 mg 2xdly.  withdr., withdr.sympt. devel. aft.long. per.dur.longt.ther.
       poss.enhanc.effs., alcoh.& phenobarbit. may dimin.effs.  Add-on ther: Adults (&gt;18 yrs) & adolesc.(12-17 yrs) weigh.50 kg   Drug interactions: Alcoh.poss.modify eff./ unpredict. S/E, CNS
                                     or more: Init. therap.dos: 500 mg 2xdly.start.on 1  day incr.up to
                                                          st
       PHLEXY 250 mg/ml, (Ascendis) Dezzo Trading [P/S]  1 500 mg 2xdly.depend.on clinic. respons.& toler. Make dos.chang.  eff.of CNS depress. phenytoin/phenobarb./carbamazepine & Na
       Phenytoin Na                  in 500 mg 2xdly.incr./decr.every 2-4 wks.  valproate low.plasma conc., petit mal status epilept. with valproic
       Indications: Prevent. & treatm.of seiz.dur./aft. neurosurg., stat.  Adolesc.(12-17 yrs) weigh.less than 50 kg when indicat: Init.  acid, mutual potent.of effs. with other centr.act.meds.esp.with alcoh.
       epileptof grand mal type.     therap.dos: 10 mg/kg 2xdly.start.on 1  day incr.up to 30 mg/kg 2xdly.   SABRIL, Sanofi-Aventis [P/S]
                                                    st
       (S3) INJ, 45/2.5/0493. 250 mg/5 ml.  depend.on clinic.respons.& toler. Dos.chang.not exceed.incr./decr.of   Vigabatrin.
       702914-002: 10x5 ml, R2 779,49  10 mg/kg 2xdly every 2 wks.using low.effect. dos.  Indications: Treatm.in combinat.with other anti-epilept.agents for
       Dosage: Individ. Optim.contr.often achiev.with ser. lev. betw. 10-  Contraindications: Pyrrolidone derivat. hypersens., pregn., lactat.  pts.with resist.part.epilepsy with/without second.generalisat.where
       20 mcg/ml. Infus.rate not to exceed 50 mg/min. in adults & 1-3 mg/  Side effects: Somnol., asthen., dizzin., infect., nasopharyngit., bld.  all other appropr.drug combinats.inadeq./not tolerat.
       kg/min in neonates.           dyscras., drug react.with eosinophil.& syst.sympt., anorex., weight   (S3) TABS. 28/2.5/0021.
       Status epilept: Adults: Load.dos: 10-15 mg/kg bm IV over 20 mins.   chang., hyponatraem., psych.disords.incl.psychot.disords., suic., at-  809594-005: 500 mg, 100, R1 692,23
       follow.by maint.dos of 300-400 mg/day with max.of 600 mg dly.   tempt.suic, suic.ideat., hostilit., CNS effs., atax., convuls., headache,   Dosage: Do not init.as monother. Treatm.to be initiat.only by neurolo-
       Childr: Load.dos: 10-20 mg/kg bm IV at rate not exceed. 1-3 mg/  trem., bal.disords., hyperkines., attent.disturbs., memory impairm.,   gist who treat epilepsy. Max recomm.dos.3 g/day not to be exceed.
       kg/min. Maint.dos.(oral if poss.): 4-8 mg/kg/day admin.in div.dos.  lethargy, choreoathetos., diplop., blurr.vis., vertigo, incr. cough, GI   Adults: Init. 1 g/day admin.once or twice dly.onto curr. regimen.
       In neurosurg.(for prophylax.& seiz.treatm.). Admin IV load.dos.  disturbs., pancreatit., hepat.fail., hepatit., skin reacts.incl.tox.epiderm.  Titr.in 0,5 g increm.wkly.depend.on respons. & tolerabil. Max.effic.
       follow.by maint.dos.(oral if poss). Indiv.to prov.max.benef. Effect.ser.  necrolys./ Stev. Johns.syndr./erythema multiforme, alopec., fatig., ac-  in range of 2-3 g/ day.
       lev usually 40-80 µmol/L. Do not exceed admin.rate of 50 mg/min in   cid. inj., abnorm.liv. funct., myalg., musc. weakn.  Childr: Recomm.start.dos: 40 mg/kg/day Max.dos. not to be exceed.
       adults and 1-3 mg/kg/min.in neonates  Warnings and special precautions: Reproduct. toxic.in anim.  Recomm.maint.dos: 10-15 kg: 1-2 tabs/day. 15-30 kg: 2-3 tabs/day.
       Contraindications: Porphyr., sinus bradycard., SA block, 2nd & 3rd   studies, grad.withdr., limit.exper.in 65 yrs. & old., monit.ren.funct.  30-50 kg: 3-6 tabs/day. &gt;50 kg: 4-6 tabs/day.
       degree AV-block, Adams Stokes syndr., hydantoin prod.hypersens.,  in sev.imp.hepat. funct., plasma lev.monit.req.in ren.& hepat.insuff.,   Contraindications: Pregn.& lactat., ren.impairm. with creatin.
       Side effects: Most notable: Sev.cardiotox. reacts., CNS depress.,   monit. for signs of depress.&/suic.ideat./behav.& init. appropr.treatm.,   clear.&lt;60 ml/min., pre-exist.clinic. signific. vis.field defects, concom.
       hypotens., rickets, reduc. BMD, osteomalac. Freq: Nervousn., drow-  excret.in breast milk, not indic. in childr.und.12 yrs.  other retinotox. drugs.
       sin., vertigo, headache, atax., decr.coordinat., nystagmus, paraesthes.,   Interactions: Meds excret.by act.tubul.secret. may reduc.ren.clear.  Side effects: Irrevers.vis.field defects esp.males, eye. disords., re-
       somnol., N&V, motor twitch., polyarthropathy, interstit.nephrit., phle-  of metabolite, incr.anorex.risk with concom.topiramate.  bound seiz.with abrupt withdr., incr. seiz.freq./onset of new types.
       bit. Less freq: Hodgkin’s dis., lymphoma, leukopen., thrombocytopen.,   seiz.esp.those with myoclon.seiz.being partic.liable, CNS effs., fatig.,
       granulocytopen., agranulocytos., pancytopen. with/-out bone marr.  RIVOTRIL, (Adcock Ingram) Roche [P/S]  excitat.& agitat.in childr., somnol., asthen., mass gain, trem., oed., an-
       suppress., macrocytos., megloblast.anaem., anaphylactoid react.,   Clonazepam.  gioed., urticar., psych. events incl.psychot.sympts.& suicid.attempts,
       anaphylax., hypersens.syndr., periarterit. nodosa, insom., ment.con-  Indications: Epilep.dis., panic disord.with/without agorophob.  atax., encephalopath.sympts., GI disturbs., rash, sedat. eff.decr.with
       fus., ton.seiz., slurr. speech, dyskines., dyston., trem., asterix., sens.   (S5) INJ, [P/S] F/2.5/187, H/34/128. 1 mg/ml.  contin. treatm., decr.in HB.
       periph. neuropathy, taste pervers., alt.resp.funct. incl. arrest, pneu-  761060-006: 5+dil, R258,56  Special precautions: Teratogenic.in animals., only use aft.caref.as-
       monit., constip., gingiv.hyperplas., liv. damage, tox.hepatit., morbili-  Dosage: Use only aft.addit.of 1 ml diluent supplied. Dilut.for in-  sessm.of benef.vs risk compar. with alternat., opthalmolog.consultat.
       form skin rash, purpur. rash, lupus erythematos., Stev.-John. syndr.,   fus.1 amp:85 ml dil. Pref.use glass contain./infus.immed.or within   advis.with systemat. screen.exam.for vis.field defects bef.init. treatm.
       TEN, lip enlargem., hypertrichos., Dupuytren contract., coars.fac.  4 hrs.if PVC bags used. Precipitat.occurs with sod.bicarbon.as dil.  & at 6 mnth.interv., pts.to report new vis. prob. & ref.to ophthalmol.,
       feat., SLE, Peyronie dis., inj.site necros., immunoglobul.abnormalit.  Stat.epileptic: Infts.& childr: 0,5 mg slow IVI/IV infus. Adults: 1   consid.grad.discont.if vis. chang.observ., excret.in breast milk, el-
       Warnings and special precautions: Alterat.in card. & resp.  amp slow IVI. May be repeat. by IV infus. 1-4 mg usual.requir. Rate   derly, mild to mod.ren.impairm., grad.withdr.over 2-4 wks., advis.
       funct.with rapid IV admin., IM route not recomm., admin.as addit.to   of inj.not to exceed 0,25-0,5 mg/min. Tot.dos.of 10 mg not to be ex-  that pt.consent form to be sign.bef. prescib., observe caref.for poss.
       IV infus.not recomm. due to lack of solubilit./result.precipitat., IV ad-  ceed. Slow IV inj: Admin.slow.with contin.ECG/ resp./BP monit. IV   adverse eff.on neurolog. funct., hist.of psychos./depress./behav. prob.
       min.through large gauge catheter should be follow. by sterile saline   infus: Infus.time not to exceed 8 hrs. IM admin.only if IV not feas.  Drug interactions: Grad.reduct.of about 20% in phenytoin plas-
       through the same needle/ IV cath.to reduc.loc.vein.irrit., avoid.contin.  (S5) DROPS, [P/S] F/2.5/188. 2,5 mg/ml.  ma conc.
       infus., hypotens., sev.myocard.insuffic., grad.withdr./ substitut., where   835129-004: 1 drp=0,1 mg, 10 ml, R205,10
       rapid substit.reqd.due to hypersens. react.use alt.ther.not belong.to   (S5) TABS, [P/S] F/2.5/189, 190.  SERINEM, (Unicorn) Unichem [P/S]
       hydantoin class, some indiv.may metabol. phenytoin slowly, elderly,   761079-010 0,5 mg, 100, R200,52  Lamotrigine.
       sev.ill, confus.states/ cerebell.dysfunct.may aris.from above optim.  761087-002: 2 mg, 100, R460,59  Indications: Adults & childr.over 12 yrs: Monother./ add-on
       ser. lev.theref.investig.at 1  sign of ac.toxic.with dos. reduct.if ser.lev.  Dosage: May be admin.with one or more anti-epilept. agents. In-  treatm.of part.epilepsy with/ without second.general.ton-clon.seiz.,
                  st
       excess.& discont.if sympts.persist, suic. ideat.& behav.report., extend.  div.accord.to age, clinic.respons. & tol. Sngl.oral dos.effect.with.30-  & in prim. gen. tonic-clon.seiz. Childr. 2-12 yrs: Add-on treatm. of
       follow-up observat. of all lymphadenopathy with alternat. anticonvuls.   60 mins. remain. effect.for 6-8 hrs in childr.& 8-12 hrs in adults. IV   part.epilep.with/without second gen. tonic-clonic seiz.not satisfact.
       ther.recomm., folic acid ther.to correct anaem. may decr.seiz.control,   dos.immed.effect.last.for 2-3 hrs.  control.with other anti-epilept.meds., mood episod.prevent.in bipol.
       discont.immed.& do not re-admin in cases of ac.hepatotox., hypers-  Oral ther: Incr. dly.dos.progress until maint.dos attain. Init.dly dos.  disord.experienc.predomin.depress.episod.
       ens. syndr report.reflect.by skin rash & hepatotox.in black pts., seek   infts.& childr.up to 10 yrs./30 kg bm: Init: 0,01-0,03 mg/kg bm/day   Lennox-Gastaut Syndr: Add-on treatm.of assoc. seiz.
       alt.ther.if skin rash of sev.nature, hyperglycaem. from the inhibit.eff.  in 2-3 div.dos. Incr. dos.by no more than 0,25-0,5 mg every 3  day un-  (S3) TABS, 46/2.5/0412, 0413, 00414, 0415
                                                             rd
       on insul.release, rais. ser.gluc.in diabet., consid.eff.of ethanol con-  til.maint.dos.of 0,1- 0,2 mg/kg bm/day achiev./ until seiz.contr./S/E   300448-001: 25 mg, 60, R101,43
       tent, use dur.pregn./poss.pregn.due to assoc. teratogenic when   prev.furth. incr. Do not exceed max.0,2 mg/kg bm/day. For optimum   300449-001: 50 mg, 60, R146,28
       admin.dur.pregn.& high.incid.of congenit. abnormalit., malign.incl.  infts & childr.dos.adjustm.drops or 0,5 mg tabs.recomm. Admin.drops   300451-001: 100 mg, 60, R242,19
       neuroblastoma report. in childr.of mothers who recd.dur.pregn., incr.   mix.with water/tea/ fruit juice & admin.with spoon. Nev.admin.drops   300452-001: 200 mg, 60, R396,06
       risk of neonat.haemorrh.& matern.bleed.dur. deliv., incr.seiz.freq.dur.  direct. from bott.into the mouth. Childr.10-16 yrs.: Init.1-1,5 mg/ day   Dosage: Do not exceed max.recomm.dos.esp.in combinat. with
       pregn.as a result of incr. prot.bind.&/incr.metabol.clear., excret. in   in 2-3 div dos. Incr.dos.by 0,25-0,5 mg every 3  day until.indiv.maint.   valproate. If calcul.dos.esp.in childr. does not equate to whole tab.
                                                        rd
       breast milk, bone min.metabol.indirect.affect.by incr.Vit.D3 metabol.  dos.achiev. (usual.3-6 mg/day).Adults: Init.dos.not to exceed 1,5 mg/  admin.dos.as equal to low.no.of whole tabs.
                                                      rd
       Interactions: Phenytoin ser.lev.incr.by: Ac. alcoh. intake/ azapro-  day in 3 div. dos. Incr.dos.by 0,5 mg every 3  day until seiz.either adeq.  Monotherapy: Adults & childr.over 12 yrs: Init: 25 mg once dly.
       pazone/phenylbutazone/ salicylates, halothane/chloramphen/  contr./undesir. effs. preclud.any furth.incr. Usual.maint.3-6 mg/day   x2 wks., follow.by 50 mg once dly. x2 wks. Thereaft.dos.may be incr.
       erythromycin/ isoniazid/ sulphonamides/felbamate/ succinimides/   suffic.but indiv.depend.upon respons. Do not exceed max. 20 mg dly   by max.50-100 mg every 1-2 wks.until optim.respons.achiev. Usual.
       amphotericin B/fluconazole/ ketoconazole/ miconazole/itracona-  dos. Dly.dos div.into 3 equal dos. If dos.not equal.div.larg.dos. giv.bef.   maint.dose: 100-200 mg/day admin.once dly. or in 2 div.dos. Some
       zole/ chlordiazepoxide/ diazepam/disulfiram/ methylphenidate/   retir. Maint. dos. best attain.aft.2-4 wks. Dly. amount.may be giv.as   pts.have reqd.500 mg/ day.
       trazodone/viloxazine/ amiodarone/ dicumarol/diltiazem/ nifedipine/   sngl.even.dos.once maint. dos.lev.reach.  Add-on therapy: Adults & childr.over 12 yrs: Pts.not tak.sod.
       ticlopidine/ cimetid./oestrog./tolbutamide/ omeprazole/ fluoxetine/  Panic disord: Adults: Init.0,25 mg 2x dly. Incr.to target dos of   valproate: Init: 50 mg once dly x2 wks. follow.by 100 mg/day in 2
       fluvoxamine/sertraline.       1 mg/day may be made aft.3 days. High.dos.of 2,3 and 4 mg/day   div.dos.x2 wks. thereaft. dos.may be incr.by max.100 mg every 1-2
       Phenytoin ser.lev.decr.by: Chron.alcoh.abuse/  are less affect.& more adverse effs. Some may benef.from dos.up   wks. until optim.respons.achiev. Usual.maint.dos. to achieve optim.
       rifampin/ ciprofloxacin/vigabatrin/sucralfate/ theophylline/ reser-  to max.4 mg/day in which case dos.may be incr.by increm.of 0,125-  respons: 200-400 mg/day in 2 div. dos.
       pine/diazoxide.               0,25 mg 2x/day every 3 days unt.panic disord.controll.or S/E make   Pts.tak.sod.valproate: Init: 25 mg every altern. day x2 wks., follow
       Phenytoin ser.lev.incr./decr.by: Carbamazepine/ phenobarb.,   furth. incr.undesir. One bedt.dos.may be pref. Treatm.to be discont.  by 25 mg once dly.x2 wks. thereaft. dos.may be incr.by max.25-50 mg/
       Na-valproate, valproic acid/ anti-neoplast.agents/ chlordiazepox-  grad.by 0,125 mg 2x dly every 3 days unt.complet.withdr.Eval.period.  day every 1-2 wks.until optim.respons.achiev. Usual maint. dos.to
       ide/ diazepam.                if long-term use consid.     achieve optim.respons: 100-200 mg/ day giv.once a day/in 2 div.dos.
       Bld.lev./effs.alt.by phenytoin: Doxycycline/ praziquantel/ ri-  Contraindications: Sev.resp.insuff., ac.narr. angl. glauc., myasth.  Pts.tak.oxcarbazepine 1200 mg/day without any other induc./
       fampin/tetracycl./lamotrigine/ azoles/ teniposide/ theophylline/  grav., sleep apnoea., safety in pregn. not est., lactat., parenter.form   inhib.of lamotrigine glucuronidat: Init: 25 mg once dly.x2 wks., fol-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page69.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page65.html">65</a>&nbsp;&nbsp;&nbsp;<a href="page66.html">66</a>&nbsp;&nbsp;&nbsp;<a href="page67.html">67</a>&nbsp;&nbsp;&nbsp;<a href="page68.html">68</a>&nbsp;&nbsp;&nbsp;<a href="page69.html">69</a>&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>
             </td>
             <td width="35%"><a href="page71.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page71.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
